Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warm Compress vs Usual Prep for Copaxone Injection Site Reactions
NCT00239993Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2005
- Primary completion
- Dec 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2005; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00239993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239993.